Treatment With Anti-C5a Antibody Improves the Outcome of H7N9 Virus Infection in African Green Monkeys

Inhibition of Complement Activation Alleviates Acute Lung Injury Induced by Highly Pathogenic Avian Influenza H5N1 Virus Infection

(2013) Shihui Sun et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms

(2013) D. Ricklin et al.   JOURNAL OF IMMUNOLOGY

Complement in Immune and Inflammatory Disorders: Therapeutic Interventions

(2013) D. Ricklin et al.   JOURNAL OF IMMUNOLOGY

Cytokine and Chemokine Levels in Patients Infected With the Novel Avian Influenza A (H7N9) Virus in China

(2013) Y. Chi et al.   JOURNAL OF INFECTIOUS DISEASES

Biological features of novel avian influenza A (H7N9) virus

(2013) Jianfang Zhou et al.   NATURE

Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection

(2013) Hai-Nv Gao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies: A Focus on Eculizumab

(2012) Jan Schmidtko et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

The effect of C1 inhibitor on myocardial ischemia and reperfusion injury

(2012) Fengxin Lu et al.   CARDIOVASCULAR PATHOLOGY

Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis

(2012) Robert A. DeAngelis et al.   IMMUNOBIOLOGY

Inhibition of terminal complement activation in severe Shiga toxin-associated HUS - perfect example for a fast track from bench to bedside

(2011) Dorothea Orth-Höller et al.   EMBO Molecular Medicine

Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza

(2011) Jan-Erik Berdal et al.   JOURNAL OF INFECTION

Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza

(2011) Rieko Ohta et al.   MICROBIOLOGY AND IMMUNOLOGY

Inhibiting the C5–C5a receptor axis

(2011) Trent M. Woodruff et al.   MOLECULAR IMMUNOLOGY

C1-Inhibitor: More Than a Serine Protease Inhibitor

(2011) Sacha Zeerleder   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons

(2010) Xavier Tillou et al.   KIDNEY INTERNATIONAL

Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis

(2010) Guojiang Chen et al.   LABORATORY INVESTIGATION

Attenuation of Cross-Talk Between the Complement and Coagulation Cascades by C5a Blockade Improves Early Outcomes After Intraportal Islet Transplantation

(2010) Kazuaki Tokodai et al.   TRANSPLANTATION

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

(2010) Guangyu Zhao et al.   Virology Journal

The role of the anaphylatoxins in health and disease

(2009) Andreas Klos et al.   MOLECULAR IMMUNOLOGY

C5 deficiency and C5a or C5aR blockade protects against cerebral malaria

(2008) Samir N. Patel et al.   JOURNAL OF EXPERIMENTAL MEDICINE